Literature DB >> 21450575

Cardiovascular risk assessment in hypertensive patients with tests recommended by the European Guidelines on Hypertension.

Manuel A Gómez-Marcos1, Luis J González-Elena, José I Recio-Rodríguez, Emiliano Rodríguez-Sánchez, Rosa Magallón-Botaya, Maria F E Muñoz-Moreno, Maria C Patino-Alonso, Luis García-Ortiz.   

Abstract

OBJECTIVE: To evaluate the usefulness of the diagnostic tests recommended by the European Society of Hypertension/Cardiology Guidelines (ESH-ESC 2007) in hypertensive patients classified as being at low or moderate risk, analyzing the change to high risk classification and the characteristics associated with such change.
METHODS: A cross-sectional study was made in 391 patients aged between 30 and 80 years recently diagnosed with arterial hypertension in the Primary Care setting. The criteria of the 2007 ESH-ESC Guidelines were followed for the evaluation of risk factors, subclinical organ damage, cardiovascular disease and cardiovascular risk. In addition to the routine tests, echocardiography, carotid ultrasound, albumin/creatinine ratio, estimated glomerular filtration rate, ankle-brachial index, pulse wave velocity and retinography were used. We established four levels of testing performed for risk classification.
RESULTS: Using the routine tests to evaluate risk (level 1), 218 (55.8%) patients were classified as being at high risk. Of the 173 patients classified as presenting low or moderate risk, the ankle-brachial index, albumin/creatinine ratio and glomerular filtration rate were determined (level 2), and 18 patients (10.4%) were classified as being at high risk. With echocardiography and carotid ultrasound (level 3), another 16 patients (10%) were raised to high risk. Finally, with pulse wave velocity and retinography (level 4), 10 additional patients (5%) were classified as presenting high risk. Patients with increased blood pressure, advanced age and women showed a 4.28-fold (95%CI: 2.01-9.16), 3.54-fold (95%CI: 1.61-7.77) and 1.36-fold (95%CI: 0.62-3.00) higher probability of being reclassified to high cardiovascular risk, respectively.
CONCLUSIONS: With the non-routine tests, 25.4% of the low or moderate risk patients were reclassified as presenting high risk.

Entities:  

Mesh:

Year:  2011        PMID: 21450575     DOI: 10.1177/1741826711401981

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  5 in total

1.  Target organ damage and control of cardiovascular risk factors in hypertensive patients. Evidence from the multicenter ESTher registry.

Authors:  R K Reibis; M Huber; M Karoff; W Kamke; R Kreutz; K Wegscheider; H Völler
Journal:  Herz       Date:  2015-01-30       Impact factor: 1.443

2.  Target organ damage in hypertension.

Authors:  Mario Fritsch Neves; Agostino Virdis; Wille Oigman
Journal:  Int J Hypertens       Date:  2012-07-05       Impact factor: 2.420

3.  Carotid Beta Stiffness Association with Thyroid Function.

Authors:  Alessandro P Delitala; Angelo Scuteri; Edoardo Fiorillo; Valeria Orrù; Edward G Lakatta; David Schlessinger; Francesco Cucca
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

4.  Guideline adherence in cardiovascular risk assessment and analysis in 15,000 hypertensive German patients in real life: results of the Prospective 3A Registry.

Authors:  Ralf Dechend; Edelgard Kaiser; Wolfgang Derer; Evelin Deeg; Andreas Busjahn; Roland E Schmieder; Uwe Zeymer
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-31       Impact factor: 3.738

5.  Association between smoking status and the parameters of vascular structure and function in adults: results from the EVIDENT study.

Authors:  Jose I Recio-Rodriguez; Manuel A Gomez-Marcos; Maria C Patino Alonso; Carlos Martin-Cantera; Elisa Ibañez-Jalon; Amor Melguizo-Bejar; Luis Garcia-Ortiz
Journal:  BMC Cardiovasc Disord       Date:  2013-12-01       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.